RxDoctor Payments Data

Amrita Narang

Pediatric Transplant Hepatology · Palo Alto, CANPI 1679831010

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Ipsen Biopharmaceuticals, Inc at 59.8% of the total.

$46,539in general payments, 2019–2025

Across 38 payments — averaging $1224.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$28K
  • Mirum Pharmaceuticals, Inc.$17K
  • Albireo Pharma, Inc.$1K
  • Travere Therapeutics, Inc.$7
$417,703in research payments, 2019–2025

Across 130 payments — averaging $3213.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Albireo Pharma, Inc.$395K
  • Mirum Pharmaceuticals, Inc.$22K

What the payments were for

  • Consulting fees$16,06135%
  • Speaking & faculty fees$23,76451%
  • Travel & lodging$5,67212%
  • Food & beverage$1,0342%
  • Education$70%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric transplant hepatology providers in Californiato place this figure against a meaningful peer group, so we don't.

Other pediatric transplant hepatology in Palo Alto

Where these figures come from

Is this you, or does something look wrong? →